By adopting interpretation-driven, clinically intelligent technologies, revenue cycle teams can ensure that every nuance of care is accurately represented. This safeguards revenue integrity while maintaining the highest standards of compliance. The post Scaling AI in Health Systems: From Innovation to Sustainable Implementation appeared first on MedCity News.
Every month a legitimate workflow improvement sits in queue, the organization pays for the problem twice: once in the inefficiency the change was supposed to fix, and again in the workaround everyone built to get through the week. The backlog doesn’t show up as a line item. It shows up everywhere else. The post The…
While there are growing efforts to link dental health with overall health, the urgency should be felt strongly not only by pregnant women but, more importantly, by their care providers and health insurance companies. For instance, pregnant women with gum disease are 3-4 times more likely to develop pre-eclampsia, an emergency condition. The post Why…
Regeneron Pharmaceuticals’ multiple myeloma drug linvoseltamab has clinical trial results showing complete responses in 90% of patients who have light chain amyloidosis, a rare blood disease. The preliminary data were presented during the annual meeting of the American Society of Clinical Oncology. The post Regeneron Cancer Drug Shows New Promise in a Rare Disease… and…
Signos raised $20 million to expand its glucose monitoring platform for weight loss, which pairs Dexcom’s over-the-counter CGM with an app that translates glucose data into personalized diet and lifestyle recommendations. The post Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss appeared first on MedCity News.
Health tech companies made several major funding announcements in May. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in May appeared first on MedCity News.
Providing access to GLP-1s only solves part of the problem. In fact, without a broader approach, it may lead to new challenges alongside the ones it aims to address. The post Telehealth is Making GLP-1s More Accessible – But Access Alone isn’t Enough appeared first on MedCity News.
The real question is whether we’re being honest with ourselves about what medical education was designed to produce, and whether our current system is still doing that job. The post Medical Education Is at a Crossroads. AI Isn’t the Problem — It’s the Mirror appeared first on MedCity News.
The rise of metabolic gene therapies represents a critical juncture for benefits management. These treatments offer genuine hope for patients with serious conditions, but they also pose significant financial challenges. The post Preparing Benefits For the Next Wave: Gene Therapy Medications appeared first on MedCity News.
May has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Abridge, Highmark Health and Merck named new executives. There were also layoffs at organizations including Innovaccer, Intermountain Health and Novartis. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.